SYNDAX PHARMACEUTICALS

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

15 May 2025 09:46:05 By NetDania Notify

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

14 May 2025 12:02:02 By NetDania Notify

Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr)

14 May 2025 09:30:00 By Nasdaq GlobeNewswire

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

12 May 2025 16:01:00 By Nasdaq GlobeNewswire

Syndax Announces Participation in May Investor Conferences

08 May 2025 07:00:01 By Nasdaq GlobeNewswire

Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood

07 May 2025 16:01:00 By Nasdaq GlobeNewswire

Syndax Reports First Quarter 2025 Financial Results and Provides Business Update

05 May 2025 16:01:00 By Nasdaq GlobeNewswire

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02 May 2025 16:05:00 By Nasdaq GlobeNewswire

Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025

28 Apr 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

09 Apr 2025 10:02:11 By NetDania Notify

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

07 Apr 2025 09:45:35 By NetDania Notify

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

04 Apr 2025 09:55:56 By NetDania Notify

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

02 Apr 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

01 Apr 2025 09:45:32 By NetDania Notify

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

05 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

03 Mar 2025 07:01:00 By Nasdaq GlobeNewswire

Syndax Announces Participation in March Investor Conferences

25 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025

24 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SYNDAX PHARMACEUTICALS INC. - COMMON STOCK

14 Jan 2025 10:12:36 By NetDania Notify